ACTIVE

Pharmacie Tilman Assesse

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result42,3 k €+125,3 %over 1 year

Gross margin362,2 k €+3,2 %over 1 year

Equity103,3 k €+17,4 %over 1 year

Workforce4,0 ETP-11,1 %over 1 year

Identity

Source · BCE/KBO

Pharmacie Tilman Assesse is a Private limited company incorporated in 1999. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Assesse. It employs on average 4,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0465.690.070
Incorporation: 29/03/1999
Legal form: Private limited company
Registered office: Chaussée de Marche 30 box A
5330 Assesse · WallonieSee on map
Contributed capital: 61 165,46 €
Latest accounts: 31/12/2025
Average workforce: 4,0 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores

Joint committees (1)

Signals

ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	362,2 k €	+3.2%	351 k €	+5.2%	333,7 k €	+15.3%	289,5 k €	+26.7%	228,5 k €
EBITDA	167,5 k €	+182%	59,3 k €	-12.6%	67,9 k €	+15.0%	59,1 k €	+45.6%	40,6 k €
Operating result	94,4 k €	+106%	45,7 k €	-30.2%	65,5 k €	+15.0%	57 k €	+48.7%	38,3 k €
Net result	42,3 k €	+125%	18,8 k €	-56.7%	43,4 k €	+36.0%	31,9 k €	+26.3%	25,3 k €
Balance sheet
Equity	103,3 k €	+17.4%	88 k €	-0.2%	88,2 k €	+4.0%	84,8 k €	+2.3%	82,9 k €
Total assets	1,1 M €	+4.1%	1,1 M €	+186%	381,1 k €	+8.6%	350,7 k €	+4.1%	336,9 k €
Cash	34,7 k €	+59.9%	21,7 k €	-78.6%	101,6 k €	+4.4%	97,3 k €	-7.6%	105,2 k €
Debts	1 M €	+3.0%	1 M €	+244%	290,9 k €	+9.4%	265,9 k €	+4.7%	254 k €
Other
Workforce	4,0 ETP	-11.1%	4,5 ETP	+12.5%	4,0 ETP	+11.1%	3,6 ETP	+2.9%	3,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 12 ended

Active mandates

PHARMA BIEN-ÊTRE

Director · 0776.600.905

Represented by Mikael Tilman

Active

Ended mandates

PHARMA BIEN-ÊTRE

Director · since 07 février 2022 · 0776.600.905

Represented by Mikael Tilman

Ended

Jean Marie HAULOT

Director · since 22 juin 2021 · until 07 février 2022

Ended

Marie Françoise BAUCHE

Managing director · since 22 juin 2021 · until 07 février 2022

Ended

Jean Marie HAULOT

Director · until 05 juin 2010

Ended

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/07/2026	18/07/2025	16/07/2024	29/06/2023	21/06/2022	30/04/2021
General meeting	29/06/2026	30/06/2025	01/06/2024	03/06/2023	04/06/2022	23/04/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	29/06/2026	02/07/2026	French	PDF
Abridged model	31/12/2024	30/06/2025	18/07/2025	French	PDF
Abridged model	31/12/2023	01/06/2024	16/07/2024	French	PDF
Abridged model	31/12/2022	03/06/2023	29/06/2023	French	PDF
Abridged model	31/12/2021	04/06/2022	21/06/2022	French	PDF
Abridged model	31/12/2020	23/04/2021	30/04/2021	French	PDF
Abridged model	31/12/2019	23/07/2020	28/07/2020	French	PDF
Abridged model	31/12/2018	27/06/2019	24/07/2019	French	PDF
Abridged model	31/12/2017	30/06/2018	20/07/2018	French	PDF
Abridged model	31/12/2016	30/06/2017	11/08/2017	French	PDF
Abridged model	31/12/2015	04/06/2016	17/06/2016	French	PDF
Abridged model	31/12/2014	06/06/2015	23/06/2015	French	PDF
Abridged model	31/12/2013	07/06/2014	10/06/2014	French	PDF
Abridged model	31/12/2012	01/06/2013	10/06/2013	French	PDF
Abridged model	31/12/2011	02/06/2012	05/06/2012	French	PDF
Abridged model	31/12/2010	04/06/2011	14/06/2011	French	PDF
Abridged model	31/12/2009	05/06/2010	07/06/2010	French	PDF
Abridged model	31/12/2008	06/06/2009	08/06/2009	French	PDF
Abridged model	31/12/2007	30/06/2008	01/07/2008	French	PDF
Abridged model	31/12/2006	02/06/2007	05/06/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 12 ended

Active mandates

PHARMA BIEN-ÊTRE

Director · 0776.600.905

Represented by Mikael Tilman

Active

Ended mandates

PHARMA BIEN-ÊTRE

Director · since 07 février 2022 · 0776.600.905

Represented by Mikael Tilman

Ended

Jean Marie HAULOT

Director · since 22 juin 2021 · until 07 février 2022

Ended

Marie Françoise BAUCHE

Managing director · since 22 juin 2021 · until 07 février 2022

Ended

Jean Marie HAULOT

Director · until 05 juin 2010

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates13/02/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DENOMINATION
PDF
Mandates25/02/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates25/06/2021
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
PDF
Restructuring11/05/2021
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Mandates10/08/2016
DEMISSIONS, NOMINATIONS
PDF
Restructuring19/06/2014
DENOMINATION - OBJET - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Restructuring17/04/2014
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Capital / shares02/01/2012
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 202542,3 k €↑
2024
Annual accounts 202418,8 k €↓
2024
Name changePharmacie Tilman Assesse
2023
Annual accounts 202343,4 k €↑
2022
Annual accounts 202231,9 k €↑
2021
Annual accounts 202125,3 k €↑
2020
Annual accounts 2020-24,2 k €↓
2019
Annual accounts 201912,7 k €↑
2018
Annual accounts 2018-7,8 k €↑
2017
Annual accounts 2017-48,1 k €↑
2016
Annual accounts 2016-77,9 k €↓
2015
Annual accounts 2015-38,2 k €↓
2014
Annual accounts 2014-15,2 k €↓
2013
Annual accounts 201315,5 k €↑
2013
Name changePharmacie Haulot-Bauche
2012
Annual accounts 201214,4 k €↑
2011
Annual accounts 201113,5 k €↑
2010
Annual accounts 201012,9 k €↑
2009
Annual accounts 200912,6 k €↓
2008
Annual accounts 200814 k €↓
2007
Annual accounts 200714,2 k €↓
2006
Annual accounts 200616 k €
2006
Name changeFARMA-BROGNE
29/03/1999
IncorporationPrivate limited company

Pharmacie Tilman Assesse

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline